| 2026-08-17 | Press release | Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare |
| 2026-08-12 | Press release | Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis |
| 2026-08-11 | Press release | Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI |
| 2026-07-16 | Press release | Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance |
| 2026-06-25 | Press release | Abbott hosts conference call for second-quarter earnings |
| 2026-06-25 | Press release | EARNINGS Abbott to host conference call for second-quarter earnings July 16 Join the earnings call |
| 2026-06-22 | Press release | New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next gene |
| 2026-06-12 | Press release | Abbott declares 410th consecutive quarterly dividend |
| 2026-06-08 | Press release | New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with suppo |
| 2026-06-06 | Press release | New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis |
| 2026-06-06 | Press release | Press Releases New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis June 0 |
| 2026-05-27 | Press release | ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening |
| 2026-05-27 | Press release | Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes |
| 2026-05-27 | Press release | Press Releases Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes |
| 2026-05-26 | Press release | Press Releases Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 May 26, 2026 |
| 2026-04-28 | Press release | Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform |
| 2026-04-28 | Press release | Press Releases Abbott’s Ultreon™ 3.0 AI-powered coronary imaging platform receives FDA clearance and CE Mark Apr. 28, 20 |
| 2026-04-25 | Press release | Press Releases New clinical data showcases strength of Abbott’s technology to address abnormal heart rhythms Apr. 25, 20 |
| 2026-04-17 | Press release | Press Releases New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test Apr. 17, |
| 2026-03-30 | Press release | Press Releases Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platfo |
| 2026-03-23 | Press release | Press Releases Abbott completes acquisition of Exact Sciences Mar. 23, 2026 |
| 2026-03-20 | Press release | Press Releases Abbott acquisition of Exact Sciences set to close on March 23, 2026 Mar. 20, 2026 |
| 2026-03-12 | Press release | Press Releases Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin Mar. 12, 2026 |
| 2026-03-11 | Press release | Press Releases New study data from Abbott show diabetic ketoacidosis on the rise Mar. 11, 2026 |
| 2026-03-11 | Press release | Press Releases Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' Mar. 11, 2026 |
| 2026-02-27 | Press release | Press Releases Abbott’s next‑generation CardioMEMS™ remote heart failure monitoring reader receives FDA approval Feb. 27 |
| 2026-02-06 | Press release | Press Releases Late-breaking data show positive safety outcomes and closure rates for new Abbott device Feb. 06, 2026 |
| 2026-02-06 | Press release | Press Releases Data highlights Abbott ablation catheters’ safety and efficacy in treating people with AFib Feb. 06, 2026 |
| 2026-01-22 | Press release | Press Releases Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook Jan. 22, 2026 |
| 2026-01-20 | Regulatory report | Abbott Q4 2025 LD-2 disclosure |
| 2026-01-08 | Press release | Press Releases Sesame Workshop and Abbott debut new resources to help families build healthy habits early Jan. 08, 2026 |
| 2025-12-22 | Press release | Press Releases Abbott's Volt™ pulsed field ablation system receives FDA approval to treat patients with atrial fibrillat |
| 2025-12-12 | Press release | Press Releases Abbott raises dividend for 54th consecutive year Dec. 12, 2025 |
| 2025-11-24 | Press release | Press Releases Abbott initiates medical device correction for certain FreeStyle Libre® sensors in U.S. Nov. 24, 2025 |
| 2025-11-20 | Press release | Press Releases Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening segment Nov. 20, 20 |
| 2025-09-19 | Press release | Press Releases Abbott Declares 407th Consecutive Quarterly Dividend Sep. 19, 2025 |
| 2025-07-21 | Regulatory report | Abbott Q2 2025 LD-2 disclosure |
| 2025-07-17 | Press release | Press Releases Abbott Hosts Conference Call for Second-Quarter Earnings July 17, 2025 |
| 2025-06-20 | Press release | Press Releases New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living Wi |
| 2025-04-21 | Regulatory report | Abbott Q1 2025 LD-2 disclosure |